Malik Fady Ibraham bought CYTK
August 19, 2025 · Form 4 insider transaction
Malik Fady Ibraham bought 2,000 shares of Cytokinetics, Incorporated at $10.60 per share, a transaction worth $21.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$10.60
Total value
$21.2K
InsiderMalik Fady Ibraham
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 19, 2025
Filing dateAugust 19, 2025
Shares owned after142,610
OwnershipDirect
10b5-1 planNo
AmendedNo